Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside
Journal of Cellular Physiology · 2025-06 · 240 (6)
DOI: 10.1002/jcp.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 10.06.2025. Verfasst von Xing-Yun Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Podocytes, Puromycin Aminonucleoside, Glucuronidase, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was financially supported by the National Science and Technology Council in Taiwan (MOST109-2314-B-010-054-MY3, and NSTC113-2320-B-A49-040) and in p….
Abstract (Originalsprache)
Podocytes are highly specialized glomerular visceral epithelial cells critical for maintaining the structure and function of the glomerular filtration barrier. These cells adhere to the glomerular basement membrane (GBM) and envelop the outer surfaces of the glomerular capillaries to prevent protein leakage during blood ultrafiltration. The GBM is a dense network of extracellular matrix composed of type IV collagen, laminin, nidogen, and heparan sulfate proteoglycans. In this study, we investigated the protective effect of a heparanase inhibitor on puromycin aminonucleoside (PAN)‐induced podocyte injury. Our results demonstrate that PAN treatment significantly disrupted the cytoskeletal architecture of cultured podocytes, reducing the formation of focal adhesions and stress fibers. Interdigitating intercellular junctions were replaced by dot‐like structures with accumulated filamentous actin. Co‐treatment with the heparanase inhibitor PI‐88 effectively prevented these PAN‐induced cytoskeletal abnormalities. Furthermore, a BSA filtration assay revealed that PI‐88 attenuated PAN‐induced increases in podocyte monolayer permeability. Taken together, our findings suggest that heparanase inhibition protects against podocyte injury and may represent a potential therapeutic strategy for glomerular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Taipei, Taiwan.
ORCID-Profile: Yu-Hsien Lu, Hsiao-Hui Lee
Förderung
- This study was financially supported by the National Science and Technology Council in Taiwan (MOST109-2314-B-010-054-MY3, and NSTC113-2320-B-A49-040) and in p…
Zitieren
APA
Huang, X. Y., Lu, Y. H., & Lee, H. H. (2025). Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside. Journal of Cellular Physiology, 240(6). https://doi.org/10.1002/jcp.70053
Vancouver
Huang XY, Lu YH, Lee HH. Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside. Journal of Cellular Physiology. 2025;240(6). doi:10.1002/jcp.70053
BibTeX
@article{Huang2025,
author = {Huang, Xing-Yun and Lu, Yu-Hsien and Lee, Hsiao-Hui},
title = {Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside},
journal = {Journal of Cellular Physiology},
year = {2025},
volume = {240},
number = {6},
doi = {10.1002/jcp.70053}
}
EUVIMED